Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HUMANA INC Director's Dealing 2017

Feb 23, 2017

30145_dirs_2017-02-22_39fd9e8f-7caf-4c5c-aed7-db19dd31dfec.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HUMANA INC (HUM)
CIK: 0000049071
Period of Report: 2017-02-18

Reporting Person: LeClaire Brian P. (SVP & Chief Information Off.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-18 Humana Common M 7889 Acquired 25734 Direct
2017-02-18 Humana Common F 3202 $205.325 Disposed 22532 Direct
2017-02-22 Humana Common M 2254 $72.84 Acquired 24786 Direct
2017-02-22 Humana Common M 7450 $102.155 Acquired 32236 Direct
2017-02-22 Humana Common M 4921 $167.805 Acquired 37157 Direct
2017-02-22 Humana Common F 974 $204.66 Disposed 36183 Direct
2017-02-22 Humana Common S 26894 $205.236 Disposed 9289 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-22 Options $72.84 M 2254 Disposed 2020-02-20 Humana Common (2254) Direct
2017-02-22 Options $102.155 M 7450 Disposed 2021-02-18 Humana Common (7450) Direct
2017-02-22 Options $167.805 M 4921 Disposed 2023-02-18 Humana Common (4921) Direct
2017-02-18 Restricted Stock Units $ M 2447 Disposed Humana Common (2447) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Humana Common 134 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Options $164.645 2022-02-24 Humana Common (14913) 14913 Direct
Restricted Stock Units $ Humana Common (2186) 2186 Direct
Phantom Stock Units $ Humana Common (61) 61 Indirect

Footnotes

F1: Stock units held for the benefit of reporting person as of January 31, 2017 under the Humana Retirement & Savings Plan including a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, both exempt under Rule 16b-3(c).

F2: Right to buy pursuant to Company's 2003 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/20/13, vesting in three increments from 02/20/14 to 02/20/16.

F3: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/14, vesting in three increments from 02/18/15 to 02/18/17.

F4: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18.

F5: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19.

F6: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7: Restricted stock units granted to reporting person on 2/18/14, 100% of the award is vesting on 2/18/17.

F8: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18.

F9: Phantom Stock Units held for the benefit of reporting person as of January 31, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctation due to changes in stock price.

F10: Includes both time based (2,447) and performance based (5,442) restricted stock units that vested on 2/18/17.

F11: Price indicated reflects the purchase price for shares exercised under the 2003 Plan using the Fair Market Value on 2/22/2017. The purchase price for shares exercised under the 2011 Plan was determined using the Fair Market Value on 2/21/2017 of $205.24.

F12: Shares sold at a prices ranging from $204.870 to $205.7650.